Document is current
Any future updates will be listed below
-
Authors
Senteio, Charles https://orcid.org/0000-0002-0254-3127
Fields, Sheldon D. https://orcid.org/0000-0002-5657-7920
Pritam Singh, Ranjit Kaur https://orcid.org/0000-0002-7498-8934
Namata Kamoga, Regina Mariam
Andrews, Emma
Gandsman, Dana
Halton, Candida https://orcid.org/0009-0000-0298-0186
Rysinova, Veronika https://orcid.org/0009-0006-8838-9517
Snow, Sally https://orcid.org/0009-0008-2190-8188
- License Information
-
More Information
Article History
Received: 6 February 2025
Accepted: 29 September 2025
First Online: 20 November 2025
Declaration
:
: Not applicable.
: CS has received consultancy fees from Pfizer Inc., but has not received fees for the work associated with this article. SF has received consultancy fees from Gilead Sciences and Pfizer Inc., but has not received fees for the work associated with this article. RKPS has received consultancy fees from Pfizer Inc, but has not received fees for the work associated with this article. RMNK has received consultancy fees from Pfizer Inc, but has not received fees for the work associated with this article. EA, DG are employees of Pfizer Inc., and own shares/stock options in Pfizer Inc. CH is founder/director of Studio Health, which receives consultancy fees from Pfizer Inc. VR, SS are employees of Studio Health, which receives consultancy fees from Pfizer Inc.
